Biotechnology

Janssen Korea Ltd. and Johnson & Johnson Innovation Announced Awardees of the Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute

- Start-up companies ImagoWorks and Sibel recognized for novel health tech solutions that harness artificial intelligence, geometrical modeling and bio-integrated sensors aiming to improve the detection, prevention and and treatment of diseases SEOUL, South Korea, Nov. 5, 2019 /PRNewswire/ -- Ja...

2019-11-05 13:00 2002

Cognate BioServices announces acquisition of Cobra Biologics

- Transformative acquisition creates global cell and gene therapy manufacturing services platform for both clinical and commercial products - EW Healthcare Partners and its co-investors provide the financing for the transaction MEMPHIS, Tennessee, Nov. 5, 2019 /PRNewswire/ -- Cognate BioServices...

2019-11-05 12:32 2364

"Live bacteria" soil health and animal nutrition firm Terragen Holdings Ltd launches $20m IPO

* Australian agricultural microbial products company Terragen Holdings Ltd launches a$20 million initial public offer (IPO) of shares, comprising 80 million shares at25 cents per share * Terragen has developed and commercialised a range of biological products that use live microbes to address...

2019-11-05 06:10 2379

China Biologic Products to Report Third Quarter 2019 Financial Results

BEIJING, Nov. 4, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its third quarter 2019 financial results o...

2019-11-04 21:30 8232

Seneca Biopharma and Jiangsu QYuns Therapeutics Announce Development Plan for Potential Joint Pipeline at 7th China Renaissance Healthcare and Life Science Leadership Summit

GERMANTOWN, Maryland, Nov. 1, 2019 /PRNewswire/ -- Seneca Biopharma, Inc., (NASDAQ: SCNA), a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, and Jiangsu QYuns Therapeutics Co., Ltd., aChina-based company focused on monoclonal antibody thera...

2019-11-01 19:00 1315

Mallinckrodt and Terumo BCT Announce UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for the Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults

SYDNEY, Nov. 1, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, and Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, today announced that UVADEX®  (methoxsalen) has received regulatory approval inAustralia by th...

2019-11-01 04:35 6556

Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA

GERMANTOWN, Maryland, Oct. 31, 2019 /PRNewswire/ -- Seneca Biopharma, Inc., (Nasdaq: CUR), a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, will begin trading on the Nasdaq Capital Market under the ticker symbol, NASDAQ: SNCA beginning onN...

2019-10-31 23:00 5459

Delivering Greater Throughput And Decreased Turnaround Time For Research Labs Is The Focus Of Leica Biosystems Next Generation Digital Pathology Scanner

VISTA, California, Oct. 31, 2019 /PRNewswire/ -- Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450, its next generation digital pathology scanner. The Aperio GT 450, labeled as research use only, offers continuous rack load...

2019-10-31 06:00 2035

Icon Group Expands Cancer Care Capabilities with Purchase of Varian Adaptive Therapy Solution

PALO ALTO, California, Oct. 31, 2019 /PRNewswire/ -- Icon Group, Australia's largest dedicated provider of cancer care, with a growing reach intoNew Zealand andAsia, has made a purchase order to further improve the quality of cancer care treatment across its international network. The order inc...

2019-10-31 04:05 6639

Huakang Biomedical Signs MOU with a World Leading Fertility Group Endeavors to Develop PRC Assisted Reproductive Treatment (ART) Market

HONG KONG, Oct. 30, 2019 /PRNewswire/ -- Huakang Biomedical Holdings Company Limited ("Huakang Biomedical", the "Group", HKSE:08622) is pleased to announce that Huakang Biomedical Company Limited ("Huakang HK"), a direct wholly-owned subsidiary of the Group, entered into a Memorandum of Understan...

2019-10-30 19:00 6106

EC Approves Astellas' XOSPATA(TM) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Mutations Detected using Invivoscribe's LeukoStrat(R) CDx FLT3 Mutation Assay

SAN DIEGO, Oct. 30, 2019 /PRNewswire/ -- Invivoscribe, Inc. announced today that the European Commission (EC) has approved the Astellas drug XOSPATA™  (gilteritinib) as a monotherapy for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) withFLT3 mutations (FL...

2019-10-30 18:00 1900

CEM Corporation acquires key assets of Intavis Bioanalytical Instruments

MATTHEWS, North Carolina, Oct. 29, 2019 /PRNewswire/ -- CEM Corporation today announced that it has entered into a definitive agreement to purchase the instrumentation lines of Intavis Bioanalytical Instruments AG, with headquarters inCologne, Germany. The acquisition allows CEM to strengthen its...

2019-10-29 20:30 2446

Werum IT Solutions honored with Frost & Sullivan Customer Value Leadership Award

LONDON, Oct. 28, 2019 /PRNewswire/ -- Based on its recent analysis of the global manufacturing execution system (MES) market for pharmaceuticals, biotechnology, and cell & gene therapies, Frost & Sullivan recognizes Werum IT Solutions with the 2019 Global MES for Pharmaceuticals, Biotechnology, a...

2019-10-28 22:00 1016

Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis

- ADVISE clinical trial initiated and enrollment progressing - Evaluating patients with the clinical diagnosis of moderate-to-severe atopic dermatitis - Significant unmet need for an oral therapy in atopic dermatitis SAN DIEGO, Oct. 28, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ...

2019-10-28 20:30 3170

EW Nutrition Opens New Production Plant in China

SHANGHAI, Oct. 28, 2019 /PRNewswire/ -- On 29 October, German-based company EW Nutrition will officially open its new production plant inChina. The new plant is the next step in the successful development of EWN Biotechnology Shanghai. By offering holistic, science-backed solutions, EW Nutrition ...

2019-10-28 19:08 3330

Kazia Raises A$4.0 Million to Progress R&D Programs

SYDNEY, Oct. 28, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce the completion of a placement of ten million new fully paid ordinary shares in the Company (New Shares) to institutional, profess...

2019-10-28 10:16 7231

HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH)

SINGAPORE, Oct. 28, 2019 /PRNewswire/ -- HistoIndex announces the expansion of its AI-based digital pathology platform towards large-scale NASH preclinical programs for pharmaceutical and biotech companies to achieve quantifiable and reproducible...

2019-10-28 08:38 1867

WuXi STA's Jinshan Facility Passes EMA Inspection

SHANGHAI, Oct. 28, 2019 /PRNewswire/ -- STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announced today that its Jinshan manufacturing facility inShanghai, China has successfully passed an inspection by the European Medicines Agency (EMA) with no critical and no major fin...

2019-10-28 08:00 2796

HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH)

SINGAPORE, Oct. 26, 2019 /PRNewswire/ -- HistoIndex announces the expansion of its AI-based digital pathology platform towards large-scale NASH preclinical programs for pharmaceutical and biotech companies to achieve quantifiable and reproducible...

2019-10-26 19:00 1905

Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences

SAN FRANCISCO and SUZHOU, China, Oct. 26, 2019 /PRNewswire/ -- Adagene, Inc., a clinical stage biotech company with innovative antibody discovery and engineering technologies, announced that it is presenting its lead program at international conferences.  During the Festival of Biologics confere...

2019-10-26 18:01 1998